Report Detail

Pharma & Healthcare Global Orphan Drugs Market Opportunities and Forecast 2022-2028

  • RnM4412957
  • |
  • 28 March, 2022
  • |
  • Global
  • |
  • 164 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

This report provides a comprehensive analysis of current global Orphan Drugs market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Orphan Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Orphan Drugs market is estimated at $ 157600 million in 2021, and projected to grow at a CAGR of 11.5% to $ 337700 million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Orphan Drugs Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Orphan Drugs market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Orphan Drugs Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Orphan Drugs industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Oncology
Pulmonary
Cardio-vascular
Metabolic Disorders
Others

Segmented by Application
Baby and Child
Teenager
Adult
Other

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Sanofi
Roche
Pfizer
Novartis
Johnson & Johnson
Eli Lilly
Bristol-Myers Squibb
Biogen
AstraZeneca
Amgen
AbbVie


Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Orphan Drugs Market Status and Forecast (2017-2028)
      • 1.3.2 Global Orphan Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Orphan Drugs Supply by Company

    • 2.1 Global Orphan Drugs Sales Volume by Company
    • 2.2 Global Orphan Drugs Sales Value by Company
    • 2.3 Global Orphan Drugs Price by Company
    • 2.4 Orphan Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Orphan Drugs Market Status by Type

    • 3.1 Orphan Drugs Type Introduction
      • 3.1.1 Oncology
      • 3.1.2 Pulmonary
      • 3.1.3 Neurology
      • 3.1.4 Hematology
      • 3.1.5 Endocrinology
      • 3.1.6 Cardio-vascular
      • 3.1.7 Metabolic Disorders
      • 3.1.8 Others
    • 3.2 Global Orphan Drugs Market by Type
      • 3.2.1 Global Orphan Drugs Sales Volume by Type (2017-2022)
      • 3.2.2 Global Orphan Drugs Sales Value by Type (2017-2022)
      • 3.2.3 Global Orphan Drugs Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Orphan Drugs Market Status by Application

    • 4.1 Orphan Drugs Segment by Application
      • 4.1.1 Baby and Child
      • 4.1.2 Teenager
      • 4.1.3 Adult
      • 4.1.4 Other
    • 4.2 Global Orphan Drugs Market by Application
      • 4.2.1 Global Orphan Drugs Sales Volume by Application (2017-2022)
      • 4.2.2 Global Orphan Drugs Sales Value by Application (2017-2022)
      • 4.2.3 Global Orphan Drugs Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Orphan Drugs Market Status by Region

    • 5.1 Global Orphan Drugs Market by Region
      • 5.1.1 Global Orphan Drugs Sales Volume by Region
      • 5.1.2 Global Orphan Drugs Sales Value by Region
    • 5.2 North America Orphan Drugs Market Status
    • 5.3 Europe Orphan Drugs Market Status
    • 5.4 Asia Pacific Orphan Drugs Market Status
    • 5.5 Central & South America Orphan Drugs Market Status
    • 5.6 Middle East & Africa Orphan Drugs Market Status

    6 North America Orphan Drugs Market Status

    • 6.1 North America Orphan Drugs Market by Country
      • 6.1.1 North America Orphan Drugs Sales Volume by Country (2017-2022)
      • 6.1.2 North America Orphan Drugs Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Orphan Drugs Market Status

    • 7.1 Europe Orphan Drugs Market by Country
      • 7.1.1 Europe Orphan Drugs Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Orphan Drugs Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Orphan Drugs Market Status

    • 8.1 Asia Pacific Orphan Drugs Market by Country
      • 8.1.1 Asia Pacific Orphan Drugs Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Orphan Drugs Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Orphan Drugs Market Status

    • 9.1 Central & South America Orphan Drugs Market by Country
      • 9.1.1 Central & South America Orphan Drugs Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Orphan Drugs Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Orphan Drugs Market Status

    • 10.1 Middle East & Africa Orphan Drugs Market by Country
      • 10.1.1 Middle East & Africa Orphan Drugs Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Orphan Drugs Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Orphan Drugs Manufacturing Cost Analysis
    • 11.5 Orphan Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Orphan Drugs Sales Channel
      • 11.5.2 Orphan Drugs Distributors
    • 11.6 Orphan Drugs Downstream Major Buyers

    12 Global Orphan Drugs Market Forecast by Type and by Application

    • 12.1 Global Orphan Drugs Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Orphan Drugs Forecast by Type
      • 12.2.1 Global Orphan Drugs Sales Volume Forecast by Type
      • 12.2.2 Global Orphan Drugs Sales Value Forecast by Type
      • 12.2.3 Global Orphan Drugs Price Forecast by Type
    • 12.3 Global Orphan Drugs Forecast by Application
      • 12.3.1 Global Orphan Drugs Sales Volume Forecast by Application
      • 12.3.2 Global Orphan Drugs Sales Value Forecast by Application
      • 12.3.3 Global Orphan Drugs Price Forecast by Application

    13 Global Orphan Drugs Market Forecast by Region/Country

    • 13.1 Global Orphan Drugs Market Forecast by Region (2023-2028)
      • 13.1.1 Global Orphan Drugs Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Orphan Drugs Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Vertex Pharmaceuticals
      • 14.1.1 Company Information
      • 14.1.2 Orphan Drugs Product Introduction
      • 14.1.3 Vertex Pharmaceuticals Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Takeda
      • 14.2.1 Company Information
      • 14.2.2 Orphan Drugs Product Introduction
      • 14.2.3 Takeda Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanofi
      • 14.3.1 Company Information
      • 14.3.2 Orphan Drugs Product Introduction
      • 14.3.3 Sanofi Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Roche
      • 14.4.1 Company Information
      • 14.4.2 Orphan Drugs Product Introduction
      • 14.4.3 Roche Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Pfizer
      • 14.5.1 Company Information
      • 14.5.2 Orphan Drugs Product Introduction
      • 14.5.3 Pfizer Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Novartis
      • 14.6.1 Company Information
      • 14.6.2 Orphan Drugs Product Introduction
      • 14.6.3 Novartis Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Johnson & Johnson
      • 14.7.1 Company Information
      • 14.7.2 Orphan Drugs Product Introduction
      • 14.7.3 Johnson & Johnson Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Eli Lilly
      • 14.8.1 Company Information
      • 14.8.2 Orphan Drugs Product Introduction
      • 14.8.3 Eli Lilly Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Bristol-Myers Squibb
      • 14.9.1 Company Information
      • 14.9.2 Orphan Drugs Product Introduction
      • 14.9.3 Bristol-Myers Squibb Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Biogen
      • 14.10.1 Company Information
      • 14.10.2 Orphan Drugs Product Introduction
      • 14.10.3 Biogen Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 AstraZeneca
    • 14.12 Amgen
    • 14.13 AbbVie

    15 Conclusion

      16 Methodology

      Summary:
      Get latest Market Research Reports on Orphan Drugs. Industry analysis & Market Report on Orphan Drugs is a syndicated market report, published as Global Orphan Drugs Market Opportunities and Forecast 2022-2028. It is complete Research Study and Industry Analysis of Orphan Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,378.04
      3,567.06
      4,756.08
      2,780.34
      4,170.51
      5,560.68
      458,204.80
      687,307.20
      916,409.60
      248,710.80
      373,066.20
      497,421.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report